建構抗免疫監測點抑制因子PD1 與PDL1的嵌合抗原受體T 細胞來治療胰臟癌(3/3)

Medicine & Life Sciences

1. Anti-Idiotypic Antibodies 5%
2. atezolizumab 9%
3. Chimeric Antigen Receptors 100%
4. Cytokines 7%
5. Heterografts 5%
6. Immune Tolerance 7%
7. Immunotherapy 5%
8. In Vitro Techniques 5%
9. Neoplasms 17%
10. Pancreatic Neoplasms 29%
11. Survival Rate 9%
12. T-Lymphocytes 34%
13. Therapeutic Uses 5%
14. Tumor Microenvironment 6%